Filip Fogdestam
Corporate Officer/Principal presso AROCELL AB
Profilo
Filip Fogdestam holds the position of Logistics Director at AroCell AB.
In his past career Mr. Fogdestam occupied the position of Marketing Director & General Manager at Maiia Diagnostics AB, General Manager for Phadia AB and General Manager of MIAB Mälainvest AB.
Filip Fogdestam received an undergraduate degree from the University of Uppsala and an undergraduate degree from Swedish University of Agricultural Sciences.
Posizioni attive di Filip Fogdestam
Società | Posizione | Inizio |
---|---|---|
AROCELL AB | Corporate Officer/Principal | - |
Precedenti posizioni note di Filip Fogdestam
Società | Posizione | Fine |
---|---|---|
Maiia Diagnostics AB | Sales & Marketing | 01/09/2013 |
MIAB Mälainvest AB
MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Corporate Officer/Principal | - |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Corporate Officer/Principal | - |
Formazione di Filip Fogdestam
University of Uppsala | Undergraduate Degree |
Swedish University of Agricultural Sciences | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AROCELL AB | Health Technology |
Aziende private | 3 |
---|---|
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
MIAB Mälainvest AB
MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Health Technology |
Maiia Diagnostics AB |